vs
Side-by-side financial comparison of Distribution Solutions Group, Inc. (DSGR) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Distribution Solutions Group, Inc. is the larger business by last-quarter revenue ($518.0M vs $336.6M, roughly 1.5× Guardian Pharmacy Services, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 4.0% vs 1.2%, a 2.8% gap on every dollar of revenue. On growth, Distribution Solutions Group, Inc. posted the faster year-over-year revenue change (10.7% vs 2.2%).
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
DSGR vs GRDN — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $518.0M | $336.6M |
| Net Profit | $6.5M | $13.5M |
| Gross Margin | 32.9% | 22.7% |
| Operating Margin | 4.6% | 5.3% |
| Net Margin | 1.2% | 4.0% |
| Revenue YoY | 10.7% | 2.2% |
| Net Profit YoY | -70.6% | 46.1% |
| EPS (diluted) | $0.14 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $336.6M | ||
| Q4 25 | — | $397.6M | ||
| Q3 25 | $518.0M | $377.4M | ||
| Q2 25 | $502.4M | $344.3M | ||
| Q1 25 | $478.0M | $329.3M | ||
| Q4 24 | $480.5M | — | ||
| Q3 24 | $468.0M | $314.4M | ||
| Q2 24 | $439.5M | — |
| Q1 26 | — | $13.5M | ||
| Q4 25 | — | $20.9M | ||
| Q3 25 | $6.5M | $9.8M | ||
| Q2 25 | $5.0M | $9.0M | ||
| Q1 25 | $3.3M | $9.4M | ||
| Q4 24 | $-25.9M | — | ||
| Q3 24 | $21.9M | $-122.0M | ||
| Q2 24 | $1.9M | — |
| Q1 26 | — | 22.7% | ||
| Q4 25 | — | 21.5% | ||
| Q3 25 | 32.9% | 19.8% | ||
| Q2 25 | 33.9% | 19.8% | ||
| Q1 25 | 34.3% | 19.5% | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 33.9% | 19.4% | ||
| Q2 24 | 34.5% | — |
| Q1 26 | — | 5.3% | ||
| Q4 25 | — | 7.7% | ||
| Q3 25 | 4.6% | 4.3% | ||
| Q2 25 | 5.3% | 3.7% | ||
| Q1 25 | 4.2% | 3.9% | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 4.0% | -33.3% | ||
| Q2 24 | 3.2% | — |
| Q1 26 | — | 4.0% | ||
| Q4 25 | — | 5.3% | ||
| Q3 25 | 1.2% | 2.6% | ||
| Q2 25 | 1.0% | 2.6% | ||
| Q1 25 | 0.7% | 2.9% | ||
| Q4 24 | -5.4% | — | ||
| Q3 24 | 4.7% | -38.8% | ||
| Q2 24 | 0.4% | — |
| Q1 26 | — | $0.21 | ||
| Q4 25 | — | — | ||
| Q3 25 | $0.14 | — | ||
| Q2 25 | $0.11 | — | ||
| Q1 25 | $0.07 | — | ||
| Q4 24 | $-0.55 | — | ||
| Q3 24 | $0.46 | — | ||
| Q2 24 | $0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $69.2M | $64.9M |
| Total DebtLower is stronger | $665.5M | — |
| Stockholders' EquityBook value | $653.9M | $232.4M |
| Total Assets | $1.8B | $426.9M |
| Debt / EquityLower = less leverage | 1.02× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.9M | ||
| Q4 25 | — | $65.6M | ||
| Q3 25 | $69.2M | $36.5M | ||
| Q2 25 | $47.4M | $18.8M | ||
| Q1 25 | $65.4M | $14.0M | ||
| Q4 24 | $66.5M | — | ||
| Q3 24 | $61.3M | $37.2M | ||
| Q2 24 | $46.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $0 | ||
| Q3 25 | $665.5M | — | ||
| Q2 25 | $675.0M | — | ||
| Q1 25 | $712.4M | — | ||
| Q4 24 | $693.9M | — | ||
| Q3 24 | $704.1M | $34.3M | ||
| Q2 24 | $573.7M | — |
| Q1 26 | — | $232.4M | ||
| Q4 25 | — | $217.9M | ||
| Q3 25 | $653.9M | $195.5M | ||
| Q2 25 | $649.4M | $179.7M | ||
| Q1 25 | $636.7M | $163.2M | ||
| Q4 24 | $640.5M | — | ||
| Q3 24 | $680.8M | $133.9M | ||
| Q2 24 | $653.3M | — |
| Q1 26 | — | $426.9M | ||
| Q4 25 | — | $412.7M | ||
| Q3 25 | $1.8B | $390.0M | ||
| Q2 25 | $1.8B | $356.3M | ||
| Q1 25 | $1.8B | $334.0M | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.8B | $348.0M | ||
| Q2 24 | $1.6B | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.00× | ||
| Q3 25 | 1.02× | — | ||
| Q2 25 | 1.04× | — | ||
| Q1 25 | 1.12× | — | ||
| Q4 24 | 1.08× | — | ||
| Q3 24 | 1.03× | 0.26× | ||
| Q2 24 | 0.88× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $38.4M | $6.1M |
| Free Cash FlowOCF − Capex | $32.9M | — |
| FCF MarginFCF / Revenue | 6.3% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | 5.95× | 0.45× |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $6.1M | ||
| Q4 25 | — | $34.6M | ||
| Q3 25 | $38.4M | $28.2M | ||
| Q2 25 | $33.3M | $19.9M | ||
| Q1 25 | $-4.8M | $17.6M | ||
| Q4 24 | $45.7M | — | ||
| Q3 24 | $-17.3M | — | ||
| Q2 24 | $21.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $32.9M | $24.2M | ||
| Q2 25 | $28.7M | — | ||
| Q1 25 | $-10.4M | — | ||
| Q4 24 | $41.1M | — | ||
| Q3 24 | $-20.5M | — | ||
| Q2 24 | $18.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 6.3% | 6.4% | ||
| Q2 25 | 5.7% | — | ||
| Q1 25 | -2.2% | — | ||
| Q4 24 | 8.6% | — | ||
| Q3 24 | -4.4% | — | ||
| Q2 24 | 4.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | 1.1% | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.8% | — |
| Q1 26 | — | 0.45× | ||
| Q4 25 | — | 1.65× | ||
| Q3 25 | 5.95× | 2.87× | ||
| Q2 25 | 6.66× | 2.21× | ||
| Q1 25 | -1.46× | 1.86× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.79× | — | ||
| Q2 24 | 11.28× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DSGR
| Test Equity Segment | $206.5M | 40% |
| Gexpro Services Segment | $130.5M | 25% |
| Lawson Segment | $121.5M | 23% |
| Canada Branch Division Segment | $60.0M | 12% |
GRDN
Segment breakdown not available.